Medigen Vaccine Biologics (6547) — Financial Flexibility Index
Medigen Vaccine Biologics (6547) has a Financial Flexibility Index of 0.23x as of December 2025. Free cash flow of NT$104.61 Million (operating CF NT$101.08 Million minus capex NT$3.54 Million) represents 0% of total liabilities (NT$454.64 Million). Check Medigen Vaccine Biologics strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Medigen Vaccine Biologics Financial Flexibility Index (2012–2025)
Historical Financial Flexibility Index trend for Medigen Vaccine Biologics across 14 annual periods. See Medigen Vaccine Biologics short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Medigen Vaccine Biologics (2012–2025)
Year-by-year free cash flow to debt coverage for Medigen Vaccine Biologics. For the full company profile including market capitalisation, see Medigen Vaccine Biologics (6547) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.01x | NT$2.69 Million | NT$-49.09 Million | NT$454.64 Million | ▼ -96.0% |
| 2024 | 0.15x | NT$75.73 Million | NT$40.75 Million | NT$513.92 Million | ▲ +175.8% |
| 2023 | -0.19x | NT$-436.80 Million | NT$-477.75 Million | NT$2.25 Billion | ▲ +53.1% |
| 2022 | -0.41x | NT$-960.62 Million | NT$-1.10 Billion | NT$2.32 Billion | ▼ -136.1% |
| 2021 | 1.15x | NT$714.85 Million | NT$579.89 Million | NT$622.95 Million | ▲ +182.7% |
| 2020 | -1.39x | NT$-484.67 Million | NT$-589.97 Million | NT$349.40 Million | ▼ -265.7% |
| 2019 | -0.38x | NT$-345.27 Million | NT$-462.65 Million | NT$910.28 Million | ▲ +32.4% |
| 2018 | -0.56x | NT$-320.44 Million | NT$-356.33 Million | NT$571.10 Million | ▼ -169.6% |
| 2017 | -0.21x | NT$-128.06 Million | NT$-217.03 Million | NT$615.41 Million | ▼ -124.0% |
| 2016 | 0.87x | NT$301.05 Million | NT$-163.37 Million | NT$347.90 Million | ▼ -60.3% |
| 2015 | 2.18x | NT$673.41 Million | NT$216.26 Million | NT$309.19 Million | ▲ +473.1% |
| 2014 | -0.58x | NT$-79.37 Million | NT$-513.98 Million | NT$135.95 Million | ▲ +69.3% |
| 2013 | -1.90x | NT$-37.01 Million | NT$-72.36 Million | NT$19.46 Million | ▼ -142.4% |
| 2012 | 4.48x | NT$99.29 Million | NT$-5.47 Million | NT$22.15 Million | — |